低胱抑素C与肌酐估算肾小球滤过率比值预测肾移植后心血管事件
该单中心回顾性研究纳入385例肾移植受者,于移植后3个月用CKD-EPI和EKFC方程计算eGFRcys/eGFRcr比值。低比值(<0.7)与主要不良心血管事件(MACE)独立相关,但与死亡或移植物丢失无关。糖尿病、男性、肌肉脂肪变性和低肌肉量可能是低比值的关键因素。
要点
- 肾移植后3个月eGFRcys/eGFRcr<0.7与MACE风险独立相关。
- 低比值与死亡或移植物丢失无显著关联。
- 糖尿病、男性、肌肉脂肪变性和低肌肉量可能解释低比值。
核心结论
- 肾移植受者中低eGFRcys/eGFRcr比值与主要不良心血管事件独立相关,但与死亡或移植物丢失无关。
研究设计与样本
- 单中心回顾性研究纳入385例肾移植受者,移植后3个月用CKD-EPI和EKFC方程计算eGFRcys/eGFRcr比值。
主要发现
- CKD-EPI方程下eGFRcys/eGFRcr<0.7者106例(27.5%),EKFC方程下54例(14%)。
- 低比值与MACE独立相关:CKD-EPI方程aHR 2.46(95%CI 1.24-4.87),EKFC方程aHR 2.29(95%CI 1.11-4.72)。
- 低比值与死亡或移植物丢失无显著关联。
- CKD-EPI方程下糖尿病与低比值相关;EKFC方程下糖尿病和男性与低比值相关。
- 275例有CT数据的受者中,男性、肌肉脂肪变性与低比值相关,CKD-EPI方程下低SMI也相关,EKFC方程下糖尿病也相关。
关键数值与推荐
- eGFRcys/eGFRcr<0.7定义为低比值。
- 采用CKD-EPI和EKFC方程计算eGFR。
- CT第三腰椎层面评估骨骼肌质量指数、肌肉脂肪变性及皮下和内脏脂肪指数。
临床怎么用
- 肾移植后3个月可计算eGFRcys/eGFRcr比值,低比值(<0.7)提示MACE风险增高。
- 对低比值患者应关注糖尿病、男性、肌肉脂肪变性和低肌肉量等可能因素。
局限性
- 单中心回顾性设计。
- 仅部分受者有CT数据(275例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: A low cystatin C-based to creatinine-based estimated glomerular filtration rate (eGFR) ratio (eGFRcys/eGFRcr) is associated with poor clinical outcomes, but data in kidney transplant recipients (KTRs) remain limited. We aimed to investigate the association between low eGFRcys/eGFRcr and allograft loss, major adverse cardiovascular events (MACEs) and mortality, and to identify the reasons for such a low ratio. METHODS: This single-center retrospective study included KTRs with eGFRcys/eGFRcr determined 3 months posttransplant using the Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) and the European Kidney Function Consortium (EKFC) equations. Body composition data were obtained from a computed tomography (CT) slice at the third lumbar vertebra as follows: skeletal muscle mass index (SMI: cross-sectional muscle area divided by height squared), myosteatosis (mean muscle CT attenuation), as well as subcutaneous and visceral adipose tissue indexes. RESULTS: Among 385 KTRs, an eGFRcys/eGFRcr < 0.7 was found in 106 (27.5%) and 54 (14%) patients with the CKD-EPI and EKFC equations, respectively. A low eGFRcys/eGFRcr ratio was independently associated with MACEs whatever the equation considered (adjusted hazard ratio [aHR]: 2.46; 95% confidence interval [CI]: 1.24-4.87 for CKD-EPI, and aHR: 2.29; 95% CI: 1.11-4.72 for EKFC), but not with death or allograft loss. Using CKD-EPI equations, diabetes mellitus was associated with eGFRcys/eGFRcr < 0.7; using EKFC equations, diabetes mellitus and male sex were associated. In the 275 KTRs with available CT scan, male sex and myosteatosis were associated with low eGFRcys/eGFRcr ratio, together with low SMI for CKD-EPI equations, and diabetes mellitus for EKFC. CONCLUSION: A low eGFRcys/eGFRcr in KTRs is associated with MACEs. Diabetes mellitus, male sex, myosteatosis, and low muscle mass could be key factors of such a low ratio.
引用
- Moryoussef M, Morel A, Zaidan L, et al. Low Cystatin C-to-Creatinine Estimated GFR Ratio Predicts Post-Kidney Transplant Cardiovascular Events. Kidney Int Rep. 2025. PMID: 41278358. doi:10.1016/j.ekir.2025.08.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。